Clinical Trial Update: Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study [NA]

View source ↗

Summary

A randomized, sham-controlled trial (RESPECT) evaluating EsophyX TIF for gastroesophageal reflux disease and hiatal hernia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Hiatal Hernia

Drugs mentioned

• EsophyX

Snippet

Sponsor: EndoGastric Solutions | Conditions: Gastroesophageal Reflux Disease, Hiatal Hernia | NA | Status: COMPLETED | Results posted: 2021-12-03